| scholarly article | Q13442814 |
| P50 | author | Anders Krogh | Q4753847 |
| Anders Jacobsen | Q42865157 | ||
| Jiayu Wen | Q47451214 | ||
| Lisa B Frankel | Q47502238 | ||
| Anders H. Lund | Q55300072 | ||
| Lea H Gregersen | Q64683194 | ||
| P2860 | cites work | Asap: a framework for over-representation statistics for transcription factor binding sites | Q21092224 |
| Yes and PI3K bind CD95 to signal invasion of glioblastoma | Q24292724 | ||
| miR-145 and miR-143 regulate smooth muscle cell fate and plasticity | Q24311186 | ||
| MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells | Q24320635 | ||
| A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
| MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias | Q24564008 | ||
| MicroRNA targeting specificity in mammals: determinants beyond seed pairing | Q24607724 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 | ||
| p53 represses c-Myc through induction of the tumor suppressor miR-145 | Q24644779 | ||
| MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury | Q24647407 | ||
| Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 | ||
| Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro | Q24684410 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs | Q27861053 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Reduced accumulation of specific microRNAs in colorectal neoplasia | Q28211976 | ||
| IQGAP1 regulation and roles in cancer | Q28237517 | ||
| let-7 microRNA functions as a potential growth suppressor in human colon cancer cells | Q28237683 | ||
| MicroRNA signatures in human ovarian cancer | Q28249211 | ||
| Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells | Q28256740 | ||
| JASPAR: an open-access database for eukaryotic transcription factor binding profiles | Q29614419 | ||
| Variance stabilization applied to microarray data calibration and to the quantification of differential expression | Q29614492 | ||
| Cellular functions regulated by Src family kinases | Q29616038 | ||
| Modulation of microRNA processing by p53 | Q29620776 | ||
| Inferring microRNA activities by combining gene expression with microRNA target prediction | Q33330275 | ||
| Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth | Q33348593 | ||
| QuantPrime--a flexible tool for reliable high-throughput primer design for quantitative PCR. | Q33381878 | ||
| STAT proteins and transcriptional responses to extracellular signals | Q34069764 | ||
| Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma | Q34647028 | ||
| Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer | Q34736348 | ||
| Diagnostic and prognostic microRNAs in stage II colon cancer. | Q34803800 | ||
| Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway | Q34977594 | ||
| Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues | Q34997758 | ||
| Increases in c-Yes expression level and activity promote motility but not proliferation of human colorectal carcinoma cells | Q36012565 | ||
| MicroRNAs as oncogenes | Q36345302 | ||
| STAT1 as a key modulator of cell death | Q36644901 | ||
| MicroRNA-143 and -145 in colon cancer | Q36822477 | ||
| Uncovering growth-suppressive MicroRNAs in lung cancer | Q37112041 | ||
| microRNAs and cancer: an overview | Q37249283 | ||
| Biological principles of microRNA-mediated regulation: shared themes amid diversity | Q37293110 | ||
| Widespread deregulation of microRNA expression in human prostate cancer. | Q38297946 | ||
| Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells | Q38298451 | ||
| MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. | Q38309740 | ||
| p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. | Q39810065 | ||
| Downregulation of microRNAs-143 and -145 in B-cell malignancies | Q40076849 | ||
| MicroRNA expression profiling in prostate cancer | Q40110318 | ||
| Characterized mechanism of alpha-mangostin-induced cell death: caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells | Q40123026 | ||
| Determinants of targeting by endogenous and exogenous microRNAs and siRNAs | Q42611158 | ||
| MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma | Q42723195 | ||
| Identification of novel microRNA targets based on microRNA signatures in bladder cancer | Q44199034 | ||
| Elevated c-yes tyrosine kinase activity in premalignant lesions of the colon | Q46090920 | ||
| Birc2 (cIap1) regulates endothelial cell integrity and blood vessel homeostasis. | Q46203326 | ||
| Vangl1 protein acts as a downstream effector of intestinal trefoil factor (ITF)/TFF3 signaling and regulates wound healing of intestinal epithelium | Q46892759 | ||
| MicroRNA expression profiles in serous ovarian carcinoma. | Q53321694 | ||
| Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17 | Q79433646 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | limma | Q112236343 |
| affy | Q113334509 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colon cancer | Q18555025 |
| microRNA | Q310899 | ||
| P304 | page(s) | e8836 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | MicroRNA-145 targets YES and STAT1 in colon cancer cells | |
| P478 | volume | 5 |
| Q36140097 | A Meta-Analysis: Identification of Common Mir-145 Target Genes that have Similar Behavior in Different GEO Datasets. |
| Q35666571 | A microRNA molecular modeling extension for prediction of colorectal cancer treatment |
| Q26998025 | Alterations of microRNAs contribute to colon carcinogenesis |
| Q34523785 | An integrative analysis of cellular contexts, miRNAs and mRNAs reveals network clusters associated with antiestrogen-resistant breast cancer cells |
| Q64902925 | Antiviral RNAi in Insects and Mammals: Parallels and Differences. |
| Q39084579 | Canonical transforming growth factor-β signaling regulates disintegrin metalloprotease expression in experimental renal fibrosis via miR-29. |
| Q34273299 | Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma |
| Q53131647 | Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. |
| Q21135494 | Differential expression of microRNAs in tumors from chronically inflamed or genetic (APC(Min/+)) models of colon cancer |
| Q35163626 | Differential expression profiling of spleen microRNAs in response to two distinct type II interferons in Tetraodon nigroviridis |
| Q35227751 | Down-Regulation of miR-129-5p and the let-7 Family in Neuroendocrine Tumors and Metastases Leads to Up-Regulation of Their Targets Egr1, G3bp1, Hmga2 and Bach1. |
| Q31052484 | Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix |
| Q37687781 | Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma |
| Q36246766 | Effects of the miR-143/-145 microRNA cluster on the colon cancer proteome and transcriptome |
| Q57170401 | Epigenetic Approaches to the Treatment of Dental Pulp Inflammation and Repair: Opportunities and Obstacles |
| Q24598045 | Epigenetics of colorectal cancer |
| Q61811540 | Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment |
| Q33751085 | Gene and miRNA expression profiles of mouse Lewis lung carcinoma LLC1 cells following single or fractionated dose irradiation. |
| Q36140620 | Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells. |
| Q38338166 | Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma |
| Q31074578 | Identification of colorectal cancer-restricted microRNAs and their target genes based on high-throughput sequencing data |
| Q35155627 | Identification of miR-145 targets through an integrated omics analysis. |
| Q28744173 | Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT |
| Q39539437 | Identification of microRNA-target interaction in APRIL-knockdown colorectal cancer cells |
| Q26783563 | Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis |
| Q35565247 | Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics |
| Q30839150 | Inferring the perturbed microRNA regulatory networks from gene expression data using a network propagation based method |
| Q26863279 | Integrating non-coding RNAs in JAK-STAT regulatory networks |
| Q47221276 | Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism |
| Q36492992 | Mechanistic insights into the role of microRNAs in cancer: influence of nutrient crosstalk. |
| Q35672212 | MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis |
| Q37209635 | MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells |
| Q36922953 | MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6. |
| Q36012772 | MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF. |
| Q42251339 | MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells |
| Q38841730 | MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells |
| Q38922911 | MiR-17-5p up-regulates YES1 to modulate the cell cycle progression and apoptosis in ovarian cancer cell lines |
| Q93354312 | MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion |
| Q37994747 | MicroRNA as a novel drug target for cancer therapy |
| Q37809919 | MicroRNA in colorectal cancer: from benchtop to bedside |
| Q37924177 | MicroRNA replacement therapy for cancer |
| Q34301072 | MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells |
| Q64077982 | MicroRNA-145 inhibits growth of laryngeal squamous cell carcinoma by targeting the PI3K/Akt signaling pathway |
| Q41894824 | MicroRNA-145 inhibits the proliferation, migration and invasion of the human TCA8113 oral cancer line |
| Q34579942 | MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor |
| Q38875145 | MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells |
| Q34365790 | MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer |
| Q41412889 | MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients |
| Q34571491 | MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways |
| Q34964080 | MicroRNA-196a is a putative diagnostic biomarker and therapeutic target for laryngeal cancer. |
| Q38331867 | MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression |
| Q35785559 | MicroRNAs and STAT interplay. |
| Q37827156 | MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors |
| Q38118612 | MicroRNAs targeting EGFR signalling pathway in colorectal cancer. |
| Q96609205 | Noncoding RNAs: the shot callers in tumor immune escape |
| Q38031834 | Oncogenic signaling by tyrosine kinases of the SRC family in advanced colorectal cancer |
| Q39061591 | Overexpression of miR-145 increases the sensitivity of vemurafenib in drug-resistant colo205 cell line |
| Q36942350 | Phenotypic switching of vascular smooth muscle cells in the 'normal region' of aorta from atherosclerosis patients is regulated by miR-145 |
| Q44182311 | Placental trophoblast debris mediated feto-maternal signalling via small RNA delivery: implications for preeclampsia |
| Q39090397 | Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells |
| Q37576058 | Regulation and activity of secretory leukoprotease inhibitor (SLPI) is altered in smokers |
| Q28385646 | Regulation of a truncated form of tropomyosin-related kinase B (TrkB) by Hsa-miR-185* in frontal cortex of suicide completers |
| Q52371311 | Role of MicroRNA in Proliferation Phase of Wound Healing. |
| Q38317603 | STAT3 Inhibition Induces Apoptosis in Cancer Cells Independent of STAT1 or STAT2. |
| Q35926157 | Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma |
| Q33644513 | Signal transducers and activators of transcription-1 (STAT1) regulates microRNA transcription in interferon gamma-stimulated HeLa cells |
| Q36553958 | Stromal Expression of miR-143/145 Promotes Neoangiogenesis in Lung Cancer Development |
| Q38942860 | Synthetic miR-145 mimic inhibits multiple myeloma cell growth in vitro and in vivo |
| Q36738971 | Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma |
| Q38129926 | Targeting translational control as a novel way to treat inflammatory disease: the emerging role of microRNAs |
| Q26830734 | The Akt-associated microRNAs |
| Q90461534 | The Microrna-143/145 Cluster in Tumors: A Matter of Where and When |
| Q49164136 | The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint |
| Q37578583 | The Structure and Clinical Roles of MicroRNA in Colorectal Cancer |
| Q38009641 | The emerging functions of the p53-miRNA network in stem cell biology |
| Q36096641 | The role of microRNAs in colorectal cancer |
| Q37822465 | Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers |
| Q46550974 | Transcriptome profile of bovine elongated conceptus obtained from SCNT and IVP pregnancies |
| Q39304020 | Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer. |
| Q53529113 | Tumor suppressor miR-145 reverses drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer. |
| Q26995383 | Tumor suppressor microRNAs: a novel non-coding alliance against cancer |
| Q35035220 | Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon. |
| Q30628865 | cWords - systematic microRNA regulatory motif discovery from mRNA expression data |
| Q33802900 | miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer |
| Q90087092 | miR-145 supports cancer cell survival and shows association with DDR genes, methylation pattern, and epithelial to mesenchymal transition |
| Q52655160 | miR-145 suppresses the proliferation, invasion and migration of NSCLC cells by regulating the BAX/BCL-2 ratio and the caspase-3 cascade. |
| Q24634704 | miR-145-mediated suppression of cell growth, invasion and metastasis |
| Q21245766 | miR-449 inhibits cell proliferation and is down-regulated in gastric cancer |
| Q39773246 | miR-Explore: Predicting MicroRNA Precursors by Class Grouping and Secondary Structure Positional Alignment |
| Q35626306 | microRNA-101 is a potent inhibitor of autophagy |
| Q41972639 | microRNA-214 functions as a tumor suppressor in human colon cancer via the suppression of ADP-ribosylation factor-like protein 2. |
| Q39197874 | socs7, a target gene of microRNA-145, regulates interferon-β induction through STAT3 nuclear translocation in bladder cancer cells |
Search more.